Data retrieved from systematic literature review did not identify threshold CSF Aβ 1–42 levels that can distinguish between healthy controls and subjects with AD because there was highly significant heterogeneity and the ranges frequently overlapped.
← all excerpts
Cerebrospinal fluid β-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease--systematic review and meta-analysis.
1
—
—